First Manhattan’s Harte-Hanks HHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-32
Closed -$239 927
2024
Q1
$239 Hold
32
﹤0.01% 1370
2023
Q4
$217 Hold
32
﹤0.01% 1395
2023
Q3
$208 Hold
32
﹤0.01% 1424
2023
Q2
$175 Hold
32
﹤0.01% 1392
2023
Q1
$301 Hold
32
﹤0.01% 1474
2022
Q4
$374 Hold
32
﹤0.01% 1620
2022
Q3
$0 Sell
32
-200
-86% -$2.67K ﹤0.01% 1573
2022
Q2
$2K Hold
232
﹤0.01% 1433
2022
Q1
$1K Hold
232
﹤0.01% 1537
2021
Q4
$1K Buy
+232
New +$1.84K ﹤0.01% 1527
2020
Q3
Sell
-232
Closed 1380
2020
Q2
$0 Hold
232
﹤0.01% 1412
2020
Q1
$0 Hold
232
﹤0.01% 1402
2019
Q4
$0 Hold
232
﹤0.01% 1326
2019
Q3
$0 Buy
232
+204
+729% +$642 ﹤0.01% 1361
2019
Q2
$0 Hold
28
﹤0.01% 1403
2019
Q1
$0 Hold
28
﹤0.01% 1419
2018
Q4
$0 Hold
28
﹤0.01% 1394
2018
Q3
$0 Hold
28
﹤0.01% 1412
2018
Q2
$0 Hold
28
﹤0.01% 1381
2018
Q1
$0 Sell
28
-1
-3% -$9 ﹤0.01% 1415
2017
Q4
$0 Hold
29
﹤0.01% 1472
2017
Q3
$0 Sell
29
-285
-91% -$2.62K ﹤0.01% 1456
2017
Q2
$3K Sell
314
-220
-41% -$2.77K ﹤0.01% 1297
2017
Q1
$7K Hold
534
﹤0.01% 1227
2016
Q4
$8K Sell
534
-382
-42% -$5.79K ﹤0.01% 1197
2016
Q3
$14K Sell
916
-2,534
-73% -$41.7K ﹤0.01% 1139
2016
Q2
$54K Sell
3,450
-2,015
-37% -$35.6K ﹤0.01% 936
2016
Q1
$138K Hold
5,465
﹤0.01% 729
2015
Q4
$177K Sell
5,465
-6,570
-55% -$246K ﹤0.01% 701
2015
Q3
$424K Sell
12,035
-475
-4% -$21.4K ﹤0.01% 529
2015
Q2
$745K Sell
12,510
-510
-4% -$34.3K ﹤0.01% 475
2015
Q1
$1.01M Sell
13,020
-610
-4% -$47.2K 0.01% 424
2014
Q4
$1.05M Sell
13,630
-1,048
-7% -$68.5K 0.01% 420
2014
Q3
$934K Sell
14,678
-1,080
-7% -$73.4K 0.01% 432
2014
Q2
$1.13M Sell
15,758
-4,160
-21% -$321K 0.01% 400
2014
Q1
$1.76M Buy
19,918
+523
+3% +$40.7K 0.01% 348
2013
Q4
$1.52M Sell
19,395
-750
-4% -$61.1K 0.01% 362
2013
Q3
$1.78M Hold
20,145
0.01% 345
2013
Q2
$1.92M Buy
+20,145
New +$1.67M 0.01% 332

Other funds holding HHS

First Manhattan's HHS Position: Q2 2024 in Review

First Manhattan sold out of Harte-Hanks (HHS) in Q2 2024, closing a stake of 32 shares — an estimated $239 sold.

First Manhattan first reported a position in HHS in Q2 2013 and held it in 39 quarters. The position peaked at $1.92M in Q2 2013. 30 funds tracked by Wall St. Rank hold HHS as of Q2 2024.

  • First Manhattan reported no remaining Harte-Hanks position as of Q2 2024 after selling out during the quarter.
  • First Manhattan sold 32 Harte-Hanks shares in Q2 2024, an estimated $239.
  • First Manhattan first reported a position in Harte-Hanks in Q2 2013 and held it in 39 quarters.
  • First Manhattan's Harte-Hanks position peaked at $1.92M in Q2 2013.
  • 30 funds tracked by Wall St. Rank held Harte-Hanks as of Q2 2024.

Based on First Manhattan's 13F filing for Q2 2024, filed 14 Aug 2024.